Live Breaking News & Updates on Morinaga milk industry co ltd bifidobacterium breve b3 efficacy japanese dairy product company body fat reduction clinically demonstrated 5 billion cfu per day humanresidential bifidobacteria hrbprobiotic strain gut microbiota metabolic syndrome aiding highquality regulation health functional food deliberation committee

Morinaga Milks Probiotic Bifidobacterium breve B3 Receives Approval of Individual Recognized Registration in South Korea

Morinaga Milk Industry Co. Ltd. TOKYO2264 a leading Japanese dairy product company today announced its proprietary probiotic strainBifidobacterium breve B3 has received the approval of Individual Recognized Registration in South Korea for its clinically demonstrated efficacy in body fat reduction.

Japan , South-korea , Tokyo , Japanese , Mitsunori-watanabe-kazuaki-kajikawa , Yoshihiko-ushida , Junichi-minami-chyn , B-business-department-of-morinaga , Morinaga-milk-group , International-division , Health-functional-foods , Morinaga-milk-industry-co-ltd